Loyd A. West
Naval Medical Center Portsmouth
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Loyd A. West.
International Journal of Cancer | 2011
Scott B. Cantor; Jose Miguel Yamal; Martial Guillaud; Dennis D. Cox; E. Neely Atkinson; John L. Benedet; Dianne Miller; Thomas Ehlen; Jasenka Matisic; Dirk van Niekerk; Monique Bertrand; Andrea Milbourne; Helen E. Rhodes; Anais Malpica; Gregg Staerkel; Shahla Nader-Eftekhari; Karen Adler-Storthz; Michael E. Scheurer; Karen Basen-Engquist; Eileen H. Shinn; Loyd A. West; Anne Therese Vlastos; Xia Tao; J. Robert Beck; Calum MacAulay; Michele Follen
Testing emerging technologies involves the evaluation of biologic plausibility, technical efficacy, clinical effectiveness, patient satisfaction, and cost‐effectiveness. The objective of this study was to select an effective classification algorithm for optical spectroscopy as an adjunct to colposcopy and obtain preliminary estimates of its accuracy for the detection of CIN 2 or worse. We recruited 1,000 patients from screening and prevention clinics and 850 patients from colposcopy clinics at two comprehensive cancer centers and a community hospital. Optical spectroscopy was performed, and 4,864 biopsies were obtained from the sites measured, including abnormal and normal colposcopic areas. The gold standard was the histologic report of biopsies, read 2 to 3 times by histopathologists blinded to the cytologic, histopathologic, and spectroscopic results. We calculated sensitivities, specificities, receiver operating characteristic (ROC) curves, and areas under the ROC curves. We identified a cutpoint for an algorithm based on optical spectroscopy that yielded an estimated sensitivity of 1.00 [95% confidence interval (CI) = 0.92–1.00] and an estimated specificity of 0.71 [95% CI = 0.62–0.79] in a combined screening and diagnostic population. The positive and negative predictive values were 0.58 and 1.00, respectively. The area under the ROC curve was 0.85 (95% CI = 0.81–0.89). The per‐patient and per‐site performance were similar in the diagnostic and poorer in the screening settings. Like colposcopy, the device performs best in a diagnostic population. Alternative statistical approaches demonstrate that the analysis is robust and that spectroscopy works as well as or slightly better than colposcopy for the detection of CIN 2 to cancer.
Immunopharmacology and Immunotoxicology | 1982
Robert J. Grasso; Loyd A. West; Robert C. Guay; Thomas W. Klein
This investigation was initiated to characterize further the ability of 1 microM dexamethasone to suppress the ingestion of heat-killed Saccharomyces cerevisiae particles in cultures of murine resident peritoneal macrophages. Time course studies revealed that the inhibitory response required the continual presence of the steroid in the culture medium. In addition, increased inhibitory responses occurred after dexamethasone was supplied to previously untreated cultures of resident macrophages that became stimulated by differentiating in vitro. These findings indicate that glucocorticoids act directly on macrophages to decrease their phagocytic capacity, which in vivo would reduce host resistance.
International Journal of Immunopharmacology | 1983
Robert J. Grasso; Loyd A. West; R.C. Guay; Thomas W. Klein
This investigation examined the effects of heat-labile serum substances on the suppression of yeast phagocytosis in dexamethasone-treated cultures of murine resident peritoneal macrophages. When 4-6 day old untreated control cultures were supplemented with either heat-inactivated (56 degrees C, 30 min) or intact (non-heat-inactivated) fetal bovine serum, more than 90% of the macrophage population ingested at least 1 yeast particle during 15 min phagocytosis assays. In cultures treated with 10(-6) M dexamethasone, approximately 30% of the macrophages were phagocytic. In contrast, approximately 70% of the steroid-treated population consisted of phagocytes in cultures supplemented with intact serum. Medium shift experiments demonstrated that the type of serum present during the 15 min yeast phagocytosis assays, but not the 4-6 day incubation periods, determined the size of the phagocytic subpopulations in the treated cultures. Whereas the majority of control phagocytes ingested more than 8 yeast particles, most dexamethasone-treated phagocytes ingested far fewer than 8 particles regardless of the size of the phagocytic subpopulations. In contrast to yeast, the ingestion of latex particles was inhibited to the same extent in dexamethasone-treated cultures that contained either heat-inactivated or intact serum. Thus, dexamethasone action impairs the ability of macrophages to accumulate yeast particles even though the phagocytic subpopulation is larger in treated cultures containing intact serum. This larger subpopulation may result from the activation of the alternative complement pathway by yeast during phagocytosis.
Analytical Cellular Pathology | 2003
Richard J. Swartz; Loyd A. West; Iouri Boiko; Anais Malpica; Calum MacAulay; Anita Carraro; Martial Guillaud; Dennis D. Cox; Michele Follen
This is a methodological study exploring the use of quantitative histopathology applied to the cervix to discriminate between normal and cancerous (consisting of adenocarcinoma and adenocarcinoma in situ) tissue samples. The goal is classifying tissue samples, which are populations of cells, from measurements on the cells. Our method uses one particular feature, the IODs‐Index, to create a tissue level feature. The specific goal of this study is to find a threshold for the IODs‐Index that is used to create the tissue level feature. The main statistical tool is Receiver Operating Characteristic (ROC) curve analysis. When applied to the data, our method achieved promising results with good estimated sensitivity and specificity for our data set. The optimal threshold for the IODs‐Index was found to be 2.12.
Clinical Cancer Research | 2001
Michele Follen; E. Neely Atkinson; David Schottenfeld; Anais Malpica; Loyd A. West; Scott M. Lippman; Changping Zou; Walter N. Hittelman; Reuben Lotan; Waun Ki Hong
Military Medicine | 1992
Jerry M. Linenger; Loyd A. West
Gynecologic Oncology | 2007
J. Adrian Freeberg; J.L. Benedet; Calum MacAulay; Loyd A. West; Michele Follen
Clinical Cancer Research | 2005
Anne Therese Vlastos; Loyd A. West; E. Neely Atkinson; Iouri Boiko; Anais Malpica; Waun Ki Hong; Michele Follen
International Journal of Gynecological Cancer | 2004
Audrey Nath; Kelley Rivoire; Sung K. Chang; Loyd A. West; Scott B Cantor; Karen M Basen-Engquist; Karen Adler-Storthz; Dennis D. Cox; E. N. Atkinson; Gregg Staerkel; Calum A. MacAulay; Rebecca Richards-Kortum; M. Follen
Gynecologic Oncology | 2007
J. Adrian Freeberg; J.L. Benedet; Loyd A. West; Edward N. Atkinson; Calum MacAulay; Michele Follen